Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: 90%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,994
Total Claims
$958K
Drug Cost
141
Beneficiaries
$6,795
Cost/Patient
Risk Score Breakdown 33/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+87%
Opioid rate vs peers
4.8% vs 2.6% avg
+536%
Cost per patient vs peers
$6,795 vs $1,068 avg
+105%
Brand preference vs peers
18.4% vs 9.0% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
4.8%
Opioid Rate
530
Opioid Claims
$20K
Opioid Cost
7.9%
Long-Acting Rate
Brand vs Generic
Brand: 2,016 claims · $604K
Generic: 8,914 claims · $350K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Rifaximin | 71 | $102K |
| Apixaban | 286 | $83K |
| Insulin Aspart | 87 | $54K |
| Paliperidone Palmitate | 11 | $39K |
| Risperidone Microspheres | 29 | $37K |
| Insulin Glargine,hum.Rec.Anlog | 91 | $30K |
| Fluticasone/Umeclidin/Vilanter | 32 | $19K |
| Celecoxib | 179 | $16K |
| Dextromethorphan Hbr/Quinidine | 22 | $15K |
| Bromocriptine Mesylate | 19 | $15K |
| Mirabegron | 57 | $14K |
| Collagenase Clostridium Hist. | 28 | $14K |
| Demeclocycline Hcl | 26 | $13K |
| Ipratropium/Albuterol Sulfate | 22 | $11K |
| Vibegron | 43 | $10K |
Prescribing Profile
Patient Profile
74
Avg Age
53%
Female
2.53
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About